US FDA Commissioner Admonishes Health Care Stakeholders To Know Agency Better, Help More
Califf was candid during an FDA Science Board meeting about the agency’s limits, such as disseminating accurate information in response to rampant misinformation during COVID-19 pandemic. “We need to call out people who are outside the FDA … because this vast universe of information out there is way bigger than we can handle on our own,” he said.
You may also be interested in...
Agency publishes Prescription Drug User Fee Act rates for FY2023, the first of five covered in reauthorization of program Congress approved on 30 September as legislation added to a continuing resolution to fund federal agencies through 16 December.
Age Restriction For Weight-Loss Supplement Sales Vetoed In California But Still In States' Crosshairs
“States need to now take notice and ensure these draconian policies never again see the light of day,” says NPA head Daniel Fabricant. CRN, neutral on restriction passed in California before governor’s veto, urges lawmakers to responsibly balance consumer safety with access to supplements.
Submitting other OTC monograph program communications through CDER's NextGen Portal, including proposals to add formulations or indications to a monograph, will have to wait.